BIBLIOGRAPHY
  1. van Rosendael PJ, Delgado V, Bax JJ. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J. (2018) 39:2003–13. doi: 10.1093/eurheartj/ ehx785
  2. Bin Mahmood SU MBBS, Mori M MD, Amabile A MD, Prescher L DO, Forrest J MD, Kaple R MD, Geirsson A MD, Mangi AA MD. Risk Factors and Mortality associated with Permanent Pacemaker after Surgical or Transcatheter Aortic Valve Replacement: Early versus Late Implantation, Journal of Cardiac Surgery. 2022 Sept. JOCS-2022-ORIG-1145.R1
  3. Ravaux JM, Di Mauro M, Vernooy K, Kats S, Mariani S, Ronco D, Actis Dato G, Simons J, Hof AWV, Maessen JG, Lorusso R. Permanent pacemaker implantation following transcatheter aortic valve implantation using self-expandable, balloon-expandable, or mechanically expandable devices: a network meta-analysis. Europace. 2021 Dec 7;23(12):1998-2009.
  4. Ravaux JM, Van Kuijk SM, Di Mauro M, Vernooy K, Bidar E, Mariani S, Dato GA, Van T Hof AW, Veenstra L, Kats S, Houterman S, Maessen JG, Lorusso R; Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration. Incidence and predictors of permanent pacemaker implantation after surgical aortic v alve replacement: Data of the Netherlands Heart Registration (NHR). J Card Surg. 2021 Oct;36(10):3519-3527.
  5. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatether aortic valve implantation. J Am Coll Cardiol 2012;60:493–501
  6. De Carlo M, Giannini C, Bedogni F, Klugmann S, Brambilla N, De Marco F et al. Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantation. Am Heart J 2012;163:492–9
  7. Urena M, Webb JG, Tamburino C, Mu~noz-Garcıa AJ, Cheema A, Dager AE et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 2014;129:1233–43ù
  8. Rück A, Saleh N, Glaser N, Outcomes Following Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: SWEDEHEART Observational Study, JACC: Cardiovascular Interventions, Volume 14, Issue 19, 2021, Pages 2173-2181
  9. López-Aguilera J, Segura Saint-Gerons JM, Sánchez Fernández J, Mazuelos Bellido F, Pan Álvarez-Ossorio M, Suárez de Lezo J, Romero Moreno M, Ojeda Pineda S, Pavlovic D, Mesa Rubio D, Rodriguez Diego S, Ferreiro C, Durán E, Chavarría J, Moya González J, Suárez de Lezo J. Long-term clinical impact of permanent cardiac pacing after transcatheter aortic valve implantation with the CoreValve prosthesis: a single center experience. Europace. 2018 Jun 1;20(6):993-1000. doi: 10.1093/europace/eux046. PMID: 28472387
  10. Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS et al. Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 2015;101:1665–71
  11. Xu S, Zhang E, Qian Z, Sun J, Zou F, Wang Y, Hou X and Zou J (2022) Mid- to Long-Term Clinical and Echocardiographic Effects of Post-procedural Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med. 9:911234. doi: 10.3389/fcvm.2022.911234
  12. Greason KL, Lahr BD, Stulak JM, et al. Long-term mortality effect of early pacemaker implantation after surgical aortic valve replacement. Ann Thorac Surg. 2017;104(4):1259-1264.
  13. Bagur R, Manazzoni JM, Dumont É, et al. Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis. Heart. 2011;97(20):1687-1694.
  14. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115–23
  15. De Sisti A, Márquez MF, Tonet J, Bonny A, Frank R, Hidden-Lucet F. Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure. Pacing Clin Electrophysiol. (2012) 35:1035–43. doi: 10.1111/j.1540-8159.2012.03371.x
  16. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. (2003) 107:2932–7. doi: 10.1161/01.Cir.0000072769.17295.B1).
  17. Bjerre TJ, Loh PH, Cholteesupachai J, et al. Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation. J Invas Cardiology. 2014;26: 94–99. Pereira E, Ferreira N, Caeiro D, et al. Transcatheter aortic valve implantation and requirements of pacing over time. Pacing Clin Electrophysiol. 2013;36:559–569
  18. D’Ancona G, Pasic M, Unbehaun A, et al. Permanent pacemaker implantation after transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2011;13:373–376.
  19. Glaser N, Persson M, Dalén M, Sartipy U. Long-term Outcomes Associated With Permanent Pacemaker Implantation After Surgical Aortic Valve Replacement. JAMA Netw Open. 2021;4(7):e2116564.
  20. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, et al, ESC Scientific Document Group, 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA), European Heart Journal, Volume 42, Issue 35, 14 September 2021, Pages 3427–3520